CAS RN: 1226154-84-2
1-(4-bromophenyl)-4-piperidinol
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
96% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250316
250mg / 1g / 5g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1226154-84-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
≥95%
0
Out of Stock
Shenzhen
Inquiry
1226154-84-2 / 1-(4-bromophenyl)piperidin-4-ol
Standard CAS: 1226154-84-2
Multi CAS: No
Basic Information
copy
CAS
1226154-84-2 copy
Multi CAS
No copy
Molecular Formula
C11H14BrNO copy
Molecular Weight
256.140000 copy
Exact Mass
255.025880 copy
SMILES
C1CN(CCC1O)C2=CC=C(C=C2)Br copy
InChI
InChI=1S/C11H14BrNO/c12-9-1-3-10(4-2-9)13-7-5-11(14)6-8-13/h1-4,11,14H,5-8H2 copy
InChIKey
ACDQKDUKSOJFLN-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
14 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.45 copy
Rotatable bonds
1 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
61.6 copy
TPSA
23.47 copy
LogP / Solubility
WLOGP
2.41 copy
MLOGP
2.13 copy
XLogP3
2.6 copy
Consensus LogP
2.38 copy
Log S (ESOL)
-3.2 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.4 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.45 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.57 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy